PEAK6 Investments’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15,000
| Closed | -$309K | – | 1822 |
|
|
2023
Q3 | $309K | Buy |
15,000
+6,000
| +67% | +$123K | ﹤0.01% | 595 |
|
|
2023
Q2 | $423K | Buy |
9,000
+4,785
| +114% | +$225K | ﹤0.01% | 409 |
|
|
2023
Q1 | $177K | Buy |
4,215
+1,070
| +34% | +$44.9K | ﹤0.01% | 697 |
|
|
2022
Q4 | $120K | Buy |
+3,145
| New | +$120K | ﹤0.01% | 851 |
|
|
2022
Q3 | – | Sell |
-9,000
| Closed | -$423K | – | 2357 |
|
|
2022
Q2 | $423K | Buy |
+9,000
| New | +$423K | ﹤0.01% | 1055 |
|
|
2020
Q1 | – | Sell |
-3,341
| Closed | -$241K | – | 1654 |
|
|
2019
Q4 | $241K | Buy |
3,341
+2,994
| +863% | +$216K | ﹤0.01% | 686 |
|
|
2019
Q3 | $49K | Buy |
347
+106
| +44% | +$15K | ﹤0.01% | 926 |
|
|
2019
Q2 | $44K | Sell |
241
-206
| -46% | -$37.6K | ﹤0.01% | 964 |
|
|
2019
Q1 | $71K | Sell |
447
-745
| -63% | -$118K | ﹤0.01% | 909 |
|
|
2018
Q4 | $114K | Buy |
1,192
+838
| +237% | +$80.1K | ﹤0.01% | 938 |
|
|
2018
Q3 | $50K | Buy |
+354
| New | +$50K | ﹤0.01% | 965 |
|